Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Budai Irgalamsrendi Korhaz, II. Reumatologia Osztaly, Budapest

Orszagos Reumatologiai es Fizioterapias Intezet, I. Reumatologia Osztaly, Budapest

Markhot Ferenc Korhaz, Reumatologiai Osztaly, Eger

Pest Megyei Flor Ferenc Korhaz, Reumatologiai es Fizioterapias Osztaly, Kistarcsa

IMSP Institutel de Cardiologie, Chisinau

State Healthcare Institution of city Moscow 'City Clinical Hospital #7', Moscow

State Healthcare Institution 'Ryazan Regional Cardiology Dispensary', Ryazan

Saint-Petersburg State Healthcare Institution 'City Hospital #26', Saint Petersburg

Saint-Petersburg State Healthcare Institution 'City Mariinskiy Hospital', Saint Petersburg

Municipal Clinical Healthcare Institution 'Medical-Sanitary Unit of Novoyaroslavskiy Oil Refinery', Yaroslavl

Chernivtsi Regional Clinical Hospital, Chernivtsi

State Institution 'Institute of Urgent and Recovery Surgery n.a. V.K. Gusaka' of AMS of Ukraine, Donetsk

Communal Institution of Healthcare, Kharkiv

Institution of Therapy of AMS of Ukraine, Kharkiv

State Institution 'Institute of Microbiology and Immunology of AMS of Ukraine', Kharkiv

State Institution 'Republican Clinical Hospital of MoH of Ukraine', Kiev

Lutsk City Clinical Hospital, Lutsk

Vinnytsa Regional Clinical Hospital, Vinnytsa

Zaporizhzhia Regional Clinical Hospital, Zaporizhzhia